Singapore markets close in 44 minutes

Ono Pharmaceutical Co., Ltd. (OPHLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
18.170.00 (0.00%)
At close: 03:37PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 8.83B
Enterprise value 7.93B
Trailing P/E 10.38
Forward P/E 11.99
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)2.65
Price/book (mrq)1.64
Enterprise value/revenue 0.02
Enterprise value/EBITDA 0.04

Trading information

Stock price history

Beta (5Y monthly) 0.28
52-week change 3-24.72%
S&P500 52-week change 316.16%
52-week high 325.36
52-week low 316.66
50-day moving average 317.89
200-day moving average 319.16

Share statistics

Avg vol (3-month) 3139
Avg vol (10-day) 338
Shares outstanding 5478.56M
Implied shares outstanding 6485.01M
Float 8465.89M
% held by insiders 115.98%
% held by institutions 146.06%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.59
Forward annual dividend yield 43.26%
Trailing annual dividend rate 377.00
Trailing annual dividend yield 3423.78%
5-year average dividend yield 4N/A
Payout ratio 430.03%
Dividend date 324 Jun 2018
Ex-dividend date 427 Mar 2024
Last split factor 25:1
Last split date 328 Mar 2016

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 30 Mar 2023
Most-recent quarter (mrq)29 Sept 2023


Profit margin 25.53%
Operating margin (ttm)40.15%

Management effectiveness

Return on assets (ttm)12.26%
Return on equity (ttm)16.74%

Income statement

Revenue (ttm)489.2B
Revenue per share (ttm)1,004.38
Quarterly revenue growth (yoy)26.10%
Gross profit (ttm)N/A
EBITDA 184.72B
Net income avi to common (ttm)124.87B
Diluted EPS (ttm)1.75
Quarterly earnings growth (yoy)29.90%

Balance sheet

Total cash (mrq)141.13B
Total cash per share (mrq)291.64
Total debt (mrq)8.97B
Total debt/equity (mrq)1.15%
Current ratio (mrq)3.52
Book value per share (mrq)1,606.19

Cash flow statement

Operating cash flow (ttm)115.35B
Levered free cash flow (ttm)82.92B